Importantly, our data demonstrate that anti-CD25 treatment causes a partial depletion of Treg cells and abolishes the differences between the severe and mild forms of paracoccidioidomycosis, which indicates that the manipulation of Treg cells may prove to be a new potential therapy against this important systemic mycosis. The gene discussed is IL2RA; the disease is systemic mycosis.